Healthcare IT News May 17, 2023
Improved drug discovery and innovations in personalized treatments are among the goals for the new Target and Lead Identification Suite and Multiomics Suite.
Pfizer and Colossal Biosciences are among the biotech and pharma firms already using two new suites of artificial intelligence tools unveiled this week by Google Cloud.
WHY IT MATTERS
The new technologies, announced for general availability Tuesday at the Bio-IT World Conference & Expo in Boston, are designed to help organizations advance drug discovery and precision medicine, according to Google.
The Target and Lead Identification Suite is meant to help pharmaceutical researchers better identify the function of amino acids and predict the structure of proteins. The Multiomics Suite, meanwhile, is focused on discovery and interpretation of genomic data,...
Today's Sponsors
Today's Sponsor